Literature DB >> 6721284

Glycopyrrolate and atropine inhalation: comparative effects on normal airway function.

T J Gal, P M Suratt, J Y Lu.   

Abstract

Bronchodilation was produced in normal subjects by inhalation of high doses of a quaternary parasympatholytic agent (glycopyrrolate), and responses were compared with those of atropine and a placebo. Both drugs induced significant increases in specific airway conductance (SGaw) and forced expiratory flows, but the effects of glycopyrrolate were sustained significantly longer (greater than 6 h). Whereas atropine produced an increased heart rate (26%) and severe dry mouth in all subjects, these symptoms were absent with glycopyrrolate and placebo. Therefore, glycopyrrolate produces significant bronchodilation of long duration but free of the side effects of muscarinic blockade that characterize atropine inhalation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721284     DOI: 10.1164/arrd.1984.129.5.871

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  2 in total

1.  Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways.

Authors:  E B Haddad; H Patel; J E Keeling; M H Yacoub; P J Barnes; M G Belvisi
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 2.  Therapeutic approaches to mucus hypersecretion.

Authors:  Atsushi Yuta; James N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.